Skip to main content
Log in

Cost and Reimbursement for Three Fibroid Treatments: Abdominal Hysterectomy, Abdominal Myomectomy, and Uterine Fibroid Embolization

  • CLINICAL INVESTIGATION
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To compare costs and reimbursements for three different treatments for uterine fibroids.

Methods

Costs and reimbursements were collected and analyzed from the Thomas Jefferson University Hospital decision support database from 540 women who underwent abdominal hysterectomy (n = 299), abdominal myomectomy (n = 105), or uterine fibroid embolization (UFE) (n = 136) for uterine fibroids during 2000–2002. We used the chi-square test and ANOVA, followed by Fisher’s Least Significant Difference test, for statistical analysis.

Results

The mean total hospital cost (US$) for UFE was $2,707, which was significantly less than for hysterectomy ($5,707) or myomectomy ($5,676) (p < 0.05). The mean hospital net income (hospital net reimbursement minus total hospital cost) for UFE was $57, which was significantly greater than for hysterectomy (−$572) or myomectomy (-$715) (p < 0.05). The mean professional (physician) reimbursements for UFE, hysterectomy, and myomectomy were $1,306, $979, and $1,078, respectively.

Conclusion

UFE has lower hospital costs and greater hospital net income than abdominal hysterectomy or abdominal myomectomy for treating uterine fibroids. UFE may be more financially advantageous than hysterectomy or myomectomy for the insurer, hospital, and health care system. Costs and reimbursements may vary amongst different hospitals and regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. ACOG Committee Opinion No. 293, Uterine artery embolization, February 2004

  2. Anon (2003) The advancing role of uterine artery embolization. Medtech Insight 5:80

    Google Scholar 

  3. Floridon C, Lund N, Thomsen SG (2001) Alternative treatment for symptomatic fibroids. Curr Opin Obstet Gynecol 13:491–495

    Article  PubMed  CAS  Google Scholar 

  4. Subramanian S, Spies JB (2001) Uterine artery embolization for leiomyomata: Resource use and cost estimation. J Vasc Radiol 12:571–574

    CAS  Google Scholar 

  5. Baker CM, Winkel CA, Subramanian S, Spies JB (2002) Estimated costs for uterine artery embolization and abdominal myomectomy for uterine leiomyomata: A comparative study at a single institution. J Vasc Interv Radiol 13:1207–1210

    PubMed  Google Scholar 

  6. Al-Fozan H, Dufort J, Kaplow M, Valenti D, Tulandi T (2002) Cost analysis of myomectomy, hysterectomy, and uterine artery embolization. Am J Obstet Gynecol 187:1401–1404

    Article  PubMed  Google Scholar 

  7. Beinfeld MT, Bosch JL, Gazelle GS (2002) Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumors. Acad Radiol 9:1300–1304

    Article  PubMed  Google Scholar 

  8. Anon (1998) International classification of diseases, 5th edn. Practice Management Information Corporation, Los Angeles, CA

  9. Spies JB, Cooper JM, Worthington-Kirsch R, Lipman JC, Mills BB, Benenati JF (2004) Outcome of uterine embolization and hysterectomy for leiomyomas: Results of a multicenter study. Am J Obstet Gynecol 191:22–31

    Article  PubMed  Google Scholar 

  10. Goldberg J, Pereira L, Berghella V (2002 Pregnancy after uterine artery embolization. Obstet Gynecol 100:869–872

    Article  PubMed  Google Scholar 

  11. Goldberg J, Pereira L, Diamond J, Berghella V, Daraï E, Seinera P, Seracchioli R (2004) Pregnancy outcomes following treatment for fibroids: Uterine artery embolization versus laparoscopic myomectomy. Am J Obstet Gynecol 191:18–21

    Article  PubMed  Google Scholar 

  12. Stringer NH, Walker JC, Meyer PM (1997) Comparison of 49 laparoscopic myomectomies with 49 open myomectomies. JAAGL 4:457–464

    CAS  Google Scholar 

  13. Simon NV, Laveran RL, Cavanaugh S, Gerlach DH, Jackson JR (1999) Laparoscopic supracervical hysterectomy vs. abdominal hysterectomy in a community hospital. A cost comparison. J Reprod Med 44:339–345

    PubMed  CAS  Google Scholar 

  14. Roumm AR, Pizzi L, Goldfarb NI, Cohn H (2005) Minimally invasive: minimally reimbursed? An examination of six laparoscopic surgical procedures. Surg Innovation 12:261–287

    Article  Google Scholar 

Download references

Acknowledgments

We wish to thank Elizabeth Moxey, MBA, for her assistance in database analysis and Joanne Armstrong, M.D., for her editing suggestions.

Preliminary data from this study were presented at the Advances in Uterine Leiomyoma Research, NIH 2nd International Congress, Bethesda, February 2005, and the ACOG Annual Clinical Meeting, San Francisco, May 2005.

J.G. serves as a consultant for Biosphere Medical Inc., Rockland, MA, USA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jay Goldberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldberg, J., Bussard, A., McNeil, J. et al. Cost and Reimbursement for Three Fibroid Treatments: Abdominal Hysterectomy, Abdominal Myomectomy, and Uterine Fibroid Embolization. Cardiovasc Intervent Radiol 30, 54–58 (2007). https://doi.org/10.1007/s00270-005-0369-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-005-0369-5

Keywords

Navigation